Nuvation Bio Inc. (NUVB) Stock
NYSE · NUVB
6.07
Fundamentals
Market cap
$2.05B
Price / Earnings ratio
-13.7x
Price / Sales ratio
12.1x
Price / Book ratio
8.1x
Return on assets
-0.2%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Nuvation Bio Inc.
No description available.
SectorHealthcare
IndustryBiotechnology
Employees305
CEODr. David T. Hung M.D.
IPO DateAug 24, 2020
HeadquartersNew York, NY
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. David T. Hung M.D. | Founder, President, CEO & Chairman | 1958 |
| Mr. Philippe Pierre Sauvage | CFO & Principal Financial Officer | 1978 |
| Dr. Gary Hattersley Ph.D. | Chief Scientific Officer | 1967 |
| Mr. Moses Makunje CPA | VP of Finance and Principal Accounting & Financial Officer | 1979 |
| Dr. David C. Hanley Ph.D. | Chief Technical Operations Officer | 1970 |
| Robert DeVita | Vice President of Corporate Development & Investor Relations | — |
| Dr. Stephen Dang Ph.D. | Chief Legal Officer & Corporate Secretary | — |
| Ms. Stacy Markel | Chief People Officer | 1965 |
| Ms. Kerry A. Wentworth | Chief Regulatory Officer | 1973 |
| Ms. Colleen Sjogren | Chief Commercial Officer | 1971 |
Fundamentals
Valuation
Market cap$2.05B
Price-to-sales ratio12.09
Price-to-book value8.09
Price-earnings ratio-13.70
Return on Equity-44.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.43
Income Statement
Average volume4,670,634
EBITDA$-123.65M
1 year high (52w)$9.75
1 year low (52w)$2.99
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



